Literature DB >> 8486631

A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes. cDNA cloning and expression of leukotriene B4 omega-hydroxylase.

Y Kikuta1, E Kusunose, K Endo, S Yamamoto, K Sogawa, Y Fujii-Kuriyama, M Kusunose.   

Abstract

Isolation of cDNA clones for human leukotriene B4 (LTB4) omega-hydroxylase clearly demonstrates that the hydroxylase is a member of the cytochrome P-450 (CYP) superfamily. cDNA clones isolated from a human leukocyte cDNA library with CYP4A4 cDNA as a probe encode a protein of 520 amino acids with a molecular weight of 59,805. The deduced amino acid sequence contains an invariant cysteine in the conserved heme-binding domain near the C terminus, characteristic of the P-450 superfamily. The microsomes from yeast cells transfected with an expression vector pAAH5 carrying isolated cDNA catalyzed the omega-hydroxylation of LTB4 with a Km value of 0.71 microM, and its activity was significantly inhibited by carbon monoxide and by antisera against CYP4A4, consistent with the properties previously reported with LTB4 omega-hydroxylase in human polymorphonuclear leukocytes. The amino acid sequence of LTB4 omega-hydroxylase (P-450LTB omega) shows 31-44% similarity to those of CYP4A, CYP4B, and CYP4C, whereas less than 25% similarity was observed with any of the other P-450 families. According to the systematic classification of the P-450 superfamily, P-450LTB omega is classified into the CYP4 family but does not belong to any of the known CYP4 subfamilies. This P-450 composes a new subfamily of CYP4. RNA blot analysis indicated that mRNA hybridized to the cDNA was expressed in the polymorphonuclear leukocytes as well as leukocytes from four individuals. Isolation of the cDNA opens the way to investigate the physiological role and to regulation of the omega-hydroxylase in the inflammation process.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8486631

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  A novel murine P-450 gene, Cyp4a14, is part of a cluster of Cyp4a and Cyp4b, but not of CYP4F, genes in mouse and humans.

Authors:  Y M Heng; C S Kuo; P S Jones; R Savory; R M Schulz; S R Tomlinson; T J Gray; D R Bell
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

2.  In vitro metabolism of chlorpromazine by cytochromes P450 4F4 and 4F5 and the inhibitory effect of imipramine.

Authors:  C L Boehme; H W Strobel
Journal:  Neurotox Res       Date:  2001-08       Impact factor: 3.911

3.  Metabolic inactivation of retinoic acid by a novel P450 differentially expressed in developing mouse embryos.

Authors:  H Fujii; T Sato; S Kaneko; O Gotoh; Y Fujii-Kuriyama; K Osawa; S Kato; H Hamada
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

Review 4.  Nuclear receptors and inflammatory diseases.

Authors:  Kun Wang; Yu-Jui Yvonne Wan
Journal:  Exp Biol Med (Maywood)       Date:  2008-03-28

5.  Inhaled carbon monoxide accelerates resolution of inflammation via unique proresolving mediator-heme oxygenase-1 circuits.

Authors:  Nan Chiang; Masakazu Shinohara; Jesmond Dalli; Valbona Mirakaj; Megumi Kibi; Augustine M K Choi; Charles N Serhan
Journal:  J Immunol       Date:  2013-05-06       Impact factor: 5.422

6.  Altered leukotriene B4 metabolism in CYP4F18-deficient mice does not impact inflammation following renal ischemia.

Authors:  Valeria Winslow; Rachel Vaivoda; Aleksandr Vasilyev; David Dombkowski; Karim Douaidy; Christopher Stark; Justin Drake; Evin Guilliams; Dharamainder Choudhary; Frederic Preffer; Ivaylo Stoilov; Peter Christmas
Journal:  Biochim Biophys Acta       Date:  2014-03-14

7.  Confirmation of Ath26 locus on chromosome 17 and identification of Cyp4f13 as an atherosclerosis modifying gene.

Authors:  Juying Han; Peggy Robinet; Brian Ritchey; Heather Andro; Jonathan D Smith
Journal:  Atherosclerosis       Date:  2019-05-09       Impact factor: 5.162

8.  On the cellular metabolism of the click chemistry probe 19-alkyne arachidonic acid.

Authors:  Philippe Pierre Robichaud; Samuel J Poirier; Luc H Boudreau; Jérémie A Doiron; David A Barnett; Eric Boilard; Marc E Surette
Journal:  J Lipid Res       Date:  2016-08-18       Impact factor: 5.922

9.  Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies.

Authors:  Vandana Hirani; Anton Yarovoy; Anita Kozeska; Ronald P Magnusson; Jerome M Lasker
Journal:  Arch Biochem Biophys       Date:  2008-07-16       Impact factor: 4.013

10.  Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator-activated receptor α.

Authors:  Katarzyna Wejksza; Catalina Lee-Chang; Monica Bodogai; Jessica Bonzo; Frank J Gonzalez; Elin Lehrmann; Kevin Becker; Arya Biragyn
Journal:  J Immunol       Date:  2013-02-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.